Impact of autoimmune diseases on outcome of patients with early breast cancer

Abstract

Our aim was to analyze the impact of a concurrent autoimmune disease on outcome of patients with early breast cancer. We reviewed medical charts of patients with a diagnosis of autoimmune diseases (AD) among a population of 17.153 cases. We categorized ADs as endocrine, rheumatic, systemic, neurological diseases and vasculitis. For each patient in the study group, we matched 2 patients. The events to determine overall survival (OS) and disease free survival (DFS) were identified from follow-up data. We identified 279 (1.62%) patients with early breast cancer and concurrent ADs. The median follow-up was 7.0 years. The 10-year OS rate was 86% (95% CI, 80% to 91%) in the study group and 90% (95% CI, 86% to 93%) for the control group (p = 0.011). In patients with ER positive/HER2 negative subtype a worse OS was observed in the study group when compared to the control group (p = 0.0046); this difference remained statistically significant when the analysis was restricted to breast cancer mortality (p = 0.045). The 10-year DFS rate was 69% (95% CI, 61% to 76%) in the study group and 72% (95% CI, 66% to 77%) for the control group (p = 0.22). Autoimmunity at diagnosis of early breast cancer is associated with worse survival.

Allergen Exposure in Lymphopenic Fas-Deficient Mice Results in Persistent Eosinophilia Due to Defects in Resolution of Inflammation

“…Besides viral infection, it is also important to note that elevated rates of homeostatic proliferation are associated with some autoinflammatory syndromes, such as rheumatoid arthritis and systemic lupus erythematosus ( 10 , 36 ). Chemotherapy and bone marrow transplantation can be associated with autoimmune manifestations ( 37 ). Although studies that correlate chemotherapy with asthma induction or severity are rare, unexplained asthma symptoms in patients receiving Tamoxifen for the treatment of breast cancer have been described ( 38 ).…”

Exploring Systemic Autoimmunity in Thyroid Disease Subjects

“…Autoimmune diseases are common in Western countries with a prevalence ranging from 7.6 to 9.4% [1–3], affecting individuals' chronic morbidity, quality of life, and health care costs. It occurs more frequently in women and is one of the leading causes of death among young to middle-aged women [4].…”

Effect of chronic comorbidities on quality of life of gynecologic cancer patients in Puerto Rico

“…However, when evaluating groups of comorbidities, suffering from autoimmune diseases significantly exacerbated these dysfunctions. Several reports concurred that cancer management and survival decreases significantly in patients with autoimmune or chronic inflammatory diseases, being largely associated with a higher risk of developing immune-related adverse events in response to anticancer therapy ( 26 , 27 ). Autoimmune diseases cause a variety of side effects, which can mirror or double those experienced by cancer patients, due to the disease itself or treatments like chemotherapy or immunotherapy ( 27 ).…”